What is Vir Biotechnology Inc (VIR) stock price today?

Vir Biotechnology Inc (VIR) currently trades at $10.22 per share. The stock has a market capitalization of $1.72B and a P/E ratio of —x.

Is VIR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Vir Biotechnology Inc has a Smart Value Score of 43/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Vir Biotechnology Inc's revenue and earnings?

Vir Biotechnology Inc has trailing twelve-month (TTM) revenue of $68.56M with profit margins of 0.00%. Earnings per share (EPS) is $-3.16.

VIR

Vir Biotechnology Inc

NASDAQ: VIR · HEALTHCARE · BIOTECHNOLOGY

$10.22

+1.34% today

Updated 2026-04-30

Market cap

$1.72B

P/E ratio

—

P/S ratio

25.02x

EPS (TTM)

$-3.16

Dividend yield

—

52W range

$4 – $12

Volume

4.0M

Market cap

$1.72B

P/E ratio

—

P/S ratio

25.02x

EPS (TTM)

$-3.16

Dividend yield

—

52W range

$4 – $12

Volume

4.0M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

7.3

Growth

B+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$20.78

+103.43%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 417.80% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-30.36M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.62B	$86.18M	$74.20M	$68.56M	$68.56M
Net income	$515.84M	$-615.06M	$-521.96M	$-437.99M	$-42.92M
EPS	—	—	—	—	$-3.16
Free cash flow	$1.60B	$-800.36M	$-453.65M	$-396.61M	$-30.36M
Profit margin	31.92%	-713.69%	-703.40%	-638.87%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VIR	$1.72B	43	7.3	2.5	5.0	5.0	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Vir Biotechnology Inc trades at $10.22. Our Smart Value Score of 43/100 indicates the stock is fair. TTM revenue stands at $68.56M.

Frequently asked questions

What is Vir Biotechnology Inc's stock price?

Vir Biotechnology Inc (VIR) trades at $10.22.

Is Vir Biotechnology Inc overvalued?

Smart Value Score 43/100 (Grade D, Sell).

What is the price target of Vir Biotechnology Inc (VIR)?

The analyst target price is $20.78, representing +103.4% upside from the current price of $10.22.

What is Vir Biotechnology Inc's revenue?

TTM revenue is $68.56M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio25.02x

ROE-45.70%

Beta1.66

50D MA$9.33

200D MA$6.68

Shares out0.16B

Float0.10B

Short ratio—

Avg volume4.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VIR vs LLY →VIR vs JNJ →VIR vs ABBV →Stock screener →